financetom
MSA
financetom
/
Industrials
/
MSA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
MSA Safety IncorporatedMSA
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

MSA Safety Incorporated develops, manufactures, and supplies safety products and software that protect people and facility infrastructures in the oil, gas, petrochemical, fire service, construction, industrial manufacturing applications, heating, ventilation, air conditioning and refrigeration, utilities, military, and mining industries in North America, Latin America, and internationally.

The company's core product offerings include permanently installed fixed gas and flame detection instruments, such as permanently installed gas detection monitoring systems, and flame detectors and open-path infrared gas detectors, as well as replacement components and related services to detect the presence or absence of various gases in the air.

Its core product offerings also comprise breathing apparatus products, such as self-contained breathing apparatus; hand-held portable gas detection instruments; industrial head protection products; firefighter helmets and protective apparel; and fall protection equipment, including confined space equipment, harnesses, lanyards, and self-retracting lifelines, as well as engineered systems.

In addition, the company offers air-purifying respirators, eye and face protection products, ballistic helmets, and gas masks.

It serves distributors and end-users through indirect and direct sales channels. The company offers its product under the V-Gard, Cairns, and Gallet brand names.

MSA Safety Incorporated was founded in 1914 and is based in Cranberry Township, Pennsylvania.

Latest News >
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Jul 11, 2024
08:16 AM EDT, 07/11/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that it has regained full rights to commercialize Vafseo tablets in the US after agreeing to terminate a license agreement with CSL Vifor. Akebia said it is now allowed to deal directly with all dialysis organizations effective immediately. Akebia said CSL Vifor is entitled to quarterly...
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 11, 2024
July 11 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON STRENGTHENS PIPELINE TO LEAD IN ATOPIC DERMATITIS WITH THE COMPLETION OF THE ACQUISITION OF YELLOW JERSEY THERAPEUTICS, GAINING OWNERSHIP OF NM26 Source text for Eikon: Further company coverage: ...
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Jul 11, 2024
The US Bureau of Labor Statistics (BLS) has published this months data for the Consumer Price Index. As is normally the case, this has caused some volatility within the cryptocurrency markets. In June, the CPI for all urban consumers fell 0.1%, seasonally adjusted This represents a change of 3% over the last 12 months, not seasonally adjusted. On the news,...
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
Jul 11, 2024
July 11 (Reuters) - PepsiCo ( PEP ) missed expectations for second-quarter revenue on Thursday as a series of price hikes and competition from private-label brands slowed sales of its snacks and soda mainly in the United States, its largest market. Analysts have said that product prices, which are starting to normalize almost after two years of multiple hikes, are...
Copyright 2023-2025 - www.financetom.com All Rights Reserved